BIP Therapy EEG Study (Rybina, Ivanov & Alexandrov): EEG Normalization in Patients with Neurotic Disorders — Pavlov Institute + Army Medical Academy

Este sitio web tiene ciertas restriucciones de navegación. Le recomendamos utilizar buscadores como: Edge, Chrome, Safari o Firefox.

FREE Bored Panda childrens book with Orders $250+ Limited Time Only!

BIP Therapy EEG Study (Rybina, Ivanov & Alexandrov): EEG Normalization in Patients with Neurotic Disorders — Pavlov Institute + Army Medical Academy

I.P. Pavlov Institute of Physiology, Russian Academy of Sciences S.M. Kirov Army Medical Academy AIRES New Medical Technologies Foundation — BIP International Association Research Center Clinical EEG Study

BIP Therapy EEG Study: EEG Normalization in Patients with Neurotic Disorders — Pavlov Institute + Army Medical Academy

Authors: L.A. Rybina* (I.P. Pavlov Institute of Physiology, Russian Academy of Sciences), A.O. Ivanov** (S.M. Kirov Army Medical Academy), M.V. Alexandrov** (S.M. Kirov Army Medical Academy)
Organization: AIRES New Medical Technologies Foundation — BIP International Association Research Center
Method: Standard EEG — BIOPAC MP-150 system with EEG-100C amplifier; 16 unipolar leads (10/20 scheme); fast Fourier transformation (FFT) analysis; photostimulation 4–27 Hz
Subjects: 12 patients with neurotic disorders (mean age 32.4 ± 4.5 years, Group 1; 23.5 ± 1.5 years, Group 2)
Timeline: EEG recorded before, immediately after, and 3 weeks post-therapy

Study Overview

This study investigated the neurophysiological correlates of changes in psychoemotional status during BIP (Bio-Information Processing) therapy in patients with neurotic disorders. BIP therapy is a bioelectromagnetic therapeutic approach developed by the AIRES Foundation, targeting the electromagnetic basis of neural coordination. The research was conducted jointly by two major institutions: the Pavlov Institute of Physiology and the Army Medical Academy, giving the study significant institutional credibility.

Subject Groups

Patients were stratified into two EEG types at baseline:

  • Group 1 (n=9): "Dysrhythmic" EEG — no dominant alpha rhythm; irregular mix of alpha, theta, and fast waves. Mean age: 32.4 ± 4.5 years.
  • Group 2 (n=3): Dominant alpha rhythm with irregular zonal distribution — elevated frontal alpha, absence of normal occipital-to-frontal decrement, "machine-like" rhythm pattern.

All participants were right-handed, free of prior brain trauma or toxic/infectious brain disease, and took no stimulants. EEGs were recorded in standard conditions — light- and soundproofed chamber, awake and physically at rest.

Key Results — Group 1 (Dysrhythmic)

After BIP therapy, statistically reliable (p < 0.05) improvements in multiple parameters:

  • Alpha index increased: from 41.1 ± 4.9% (baseline) to 51.7 ± 7.2% (post-therapy)
  • Alpha modulation normalized: modulation count increased from 0±1 to 6.7 ± 0.5*
  • Excitation-inhibition ratio normalized: coefficient approached zero (−23.8 at baseline vs. −7.2 post-therapy) — indicating reduced pathological inhibition dominance
  • CNS reactivity improved: extinction of adjustment reaction improved from ~10–12 exposures to 4–7 exposures
  • Photostimulation response broadened: frequency range of assimilation reaction expanded significantly

Key Results — Group 2 (Irregular Alpha Distribution)

  • Frontal alpha index normalized: from 41.6 ± 2.9% (abnormally high frontal) to 21.7 ± 2.9* — restoring the correct occipital-dominant gradient
  • Excitation-inhibition ratio normalized: from +11.5 (excitation dominant) to −8.6 ± 3.5* (balanced, appropriate inhibition)
  • Improved CNS lability: assimilation range in photostimulation broadened

Overall Pattern and 3-Week Follow-up

9 of 12 patients (7 from Group 1, 2 from Group 2) showed EEG patterns approaching "ideal norm" at the end of therapy — well-formed alpha spindles (55–75% index in occipital leads), correct zonal distribution, frequency stability within 1 Hz. These gains were maintained at the 3-week follow-up, demonstrating persistence of the normalizing effect. The remaining 3 patients maintained their initial EEG type without deterioration.

Importantly, BIP therapy produced bidirectional normalization — correcting both hypo-activation (Group 1) and hyper-activation (Group 2) toward the same "ideal norm" target. This bidirectional regulatory pattern is characteristic of resonance-based therapeutic approaches and distinguishes them from stimulant or sedative pharmacological interventions.

Institutional Note

The collaboration between Rybina (Pavlov Institute) and Ivanov + Alexandrov (Army Medical Academy) represents two of St. Petersburg's most important research institutions engaged jointly on this work. Larisa Rybina subsequently led multiple additional EEG studies of Aires/Lifetune products over the following two decades, including the 2003 mobile phone EEG studies, the 2018, 2020, and 2025 clinical studies.

Related Studies